Home » Topics » Regulatory

Regulatory
RSS

Priority review granted to Femara as first-line breast cancer therapy

Sep. 13, 2000

AstraZeneca commences phase III trial of Seroquel for treatment of bipolar disorder

Sep. 13, 2000

Inhale and Lilly reinitiate development of inhalable Forteo; discontinue other program

Sep. 8, 2000

Combination approved for second-line treatment of hypertension

Sep. 8, 2000

Phase I trial of TOBI in ventilator-associated pneumonia initiated

Sep. 8, 2000

Bone Care launches Hectorol Injection

Sep. 7, 2000

Flavopiridol, a known antitumor agent, now reported effective in models of vascular injury

Sep. 7, 2000

FDA approves ciprofloxacin for treatment of postexposure inhalational anthrax

Sep. 7, 2000

Use of AII receptor antagonists in prevention, treatment of AMI

Sep. 7, 2000

New use for topiramate: bulimia nervosa Rx

Sep. 6, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 8, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...